I would say any rewards from lawsuits are best spe

I would say any rewards from lawsuits are best spent on securing more of the market on a global scale by signing on more partners. More partners selling products through the network means a more attractive platform. I do think a lot hinges on the pen bc the nanotech used and licensed is about as effective as it gets. Until there is another breakthrough in tech for analysis of cannabis MYDX is about as good as it gets (outside of lab) but is still only 80% on THC and lower for many of the other attributes it tests for. I am trying to be realistic I do like the analyzer but until it can be used in official capacity it truly is not where MYDX will make money. The platform and the pen feeding it is where value will be realized for MYDX. So back to your original question. While a buy back would certainly increase PPS the goal of the CEO is to care for the longterm vision for the shareholders. The chance MYDX has if awarded a large sum is to make partners and start a large network of growers and manufactures. This allows any client of MYDX, lets say a well known MJ brand/celebrity endorsed product, to gain market share quickly in any area. MYDX scales quickly and will get acquired assuming pen gets the traction in the local markets where it is partnered.